Medtronic Plc

Organisation

Building Two, Galway, Ireland

Headquarters

95000

Employees

Health Technology

Industry

Geoffrey Martha

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Price

Target

Medtronic Plc (MDT) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Medtronic Plc (MDT) share price will touch around $111.69 in next 12-months.

Currently 37 wall-street analysts regularly analyze the financials of Medtronic Plc on a frequent basis to provide recommendations along with target share price. 37 analysts offering 12-month price forecasts for Medtronic Plc (MDT) have a share price target of $111.69. This median of share price forecast represents a 27.77% upside from the latest price of $87.42 as on 13.03.26.

Medtronic Plc (MDT) Share Price Forecast

Home

US Stocks

Medtronic Plc (MDT)

Medtronic Plc Stock Forecast

Medtronic Plc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Medtronic Plc (MDT): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Medtronic Plc's share price and its median forecast price. As on 13.03.26, the difference is -6.87%

Medtronic Plc Forecast and Target Price

Medtronic Plc (MDT) Share Price Forecast

Medtronic Plc (MDT) Price vs Consensus Price Target

Medtronic Plc (MDT) Share Price Forecast v/s Share Price Today

Medtronic Plc (MDT): Difference between Current Price & Median Forecasted Price

Medtronic Plc (MDT) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price